Unknown

Dataset Information

0

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.


ABSTRACT:

Background

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignant tumor of the digestive system. Its grim prognosis is mainly attributed to the lack of means for early diagnosis and poor response to treatments. Genomic instability is shown to be an important cancer feature and prognostic factor, and its pattern and extent may be associated with poor treatment outcomes in PDAC. Recently, it has been reported that long non-coding RNAs (lncRNAs) play a key role in maintaining genomic instability. However, the identification and clinical significance of genomic instability-related lncRNAs in PDAC have not been fully elucidated.

Methods

Genomic instability-derived lncRNA signature (GILncSig) was constructed based on the results of multiple regression analysis combined with genomic instability-associated lncRNAs and its predictive power was verified by the Kaplan-Meier method. And real-time quantitative polymerase chain reaction (qRT-PCR) was used for simple validation in human cancers and their adjacent non-cancerous tissues. In addition, the correlation between GILncSig and tumor microenvironment (TME) and epithelial-mesenchymal transition (EMT) was investigated by Pearson correlation analysis.

Results

The computational framework identified 206 lncRNAs associated with genomic instability in PDAC and was subsequently used to construct a genome instability-derived five lncRNA-based gene signature. Afterwards, we successfully validated its prognostic capacity in The Cancer Genome Atlas (TCGA) cohort. In addition, via careful examination of the transcriptome expression profile of PDAC patients, we discovered that GILncSig is associated with EMT and an adaptive immunity deficient immune profile within TME.

Conclusions

Our study established a genomic instability-associated lncRNAs-derived model (GILncSig) for prognosis prediction in patients with PDAC, and revealed the potential functional regulatory role of GILncSig.

SUBMITTER: Yang H 

PROVIDER: S-EPMC9486402 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.

Yang Huijie H   Zhang Weiwen W   Ding Jin J   Hu Jingyi J   Sun Yi Y   Peng Weijun W   Chu Yi Y   Xie Lingxiang L   Mei Zubing Z   Shao Zhuo Z   Xiao Yang Y  

Frontiers in immunology 20220915


<h4>Background</h4>Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignant tumor of the digestive system. Its grim prognosis is mainly attributed to the lack of means for early diagnosis and poor response to treatments. Genomic instability is shown to be an important cancer feature and prognostic factor, and its pattern and extent may be associated with poor treatment outcomes in PDAC. Recently, it has been reported that long non-coding RNAs (lncRNAs) play a key role in maintain  ...[more]

Similar Datasets

| S-EPMC9172649 | biostudies-literature
| S-EPMC9012103 | biostudies-literature
| S-EPMC11196711 | biostudies-literature
| S-EPMC9232547 | biostudies-literature
| S-EPMC8940523 | biostudies-literature
| S-EPMC9859148 | biostudies-literature
| S-EPMC8351726 | biostudies-literature
| S-EPMC6775308 | biostudies-literature
| S-EPMC8379629 | biostudies-literature
| S-EPMC8422092 | biostudies-literature